1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hua, Q.X. Hu, S.Q. Frank, B.H. Jia, W.H. Chu, Y.C. Wang, S.H. Burke, G.T. Katsoyannis, P.G. Weiss, M.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 264 390 403 10.1006/jmbi.1996.0648 8951384 Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue. 1996 10.2210/pdb1vkt/pdb pdb_00001vkt 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2351.568 INSULIN CHAIN A, C6S, C11S, CHAIN B, H10D, P28K, K29P 1 man polymer 3410.894 INSULIN CHAIN A, C6S, C11S, CHAIN B, H10D, P28K, K29P 1 man polymer no no GIVEQSCTSISSLYQLENYCN GIVEQSCTSISSLYQLENYCN A polypeptide(L) no no FVNQHLCGSDLVEALYLVCGERGFFYTKPT FVNQHLCGSDLVEALYLVCGERGFFYTKPT B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 PANCREAS Homo sapiens human Homo sample 9606 PANCREAS Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-04-01 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1996-10-14 REL REL DATE OF DATA COLLECTION : 1995 10 6.8 298 K BRUNGER refinement X-PLOR GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A SER 6 n 6 SER 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A SER 11 n 11 SER 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B ASP 10 n 10 ASP 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B LYS 28 n 28 LYS 28 B PRO 29 n 29 PRO 29 B THR 30 n 30 THR 30 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 B ARG 22 0.147 SIDE CHAIN 2 B ARG 22 0.294 SIDE CHAIN 3 B ARG 22 0.227 SIDE CHAIN 4 B ARG 22 0.195 SIDE CHAIN 5 B ARG 22 0.277 SIDE CHAIN 6 B ARG 22 0.281 SIDE CHAIN 7 B ARG 22 0.175 SIDE CHAIN 8 B ARG 22 0.105 SIDE CHAIN 9 B ARG 22 0.232 SIDE CHAIN 10 B ARG 22 0.230 SIDE CHAIN 1 A VAL 3 79.67 179.70 1 A GLU 4 85.06 -11.21 1 A GLN 5 -112.78 -77.19 1 A CYS 7 62.50 -5.91 1 A THR 8 35.79 -119.35 1 A SER 11 -108.48 50.49 1 A SER 12 -163.03 7.80 1 B ASN 3 54.02 173.74 1 B HIS 5 61.05 68.28 1 B CYS 7 -2.07 -48.47 2 A GLU 4 -150.75 21.62 2 A GLN 5 -144.04 -112.77 2 A SER 6 -84.84 46.98 2 A CYS 7 47.26 19.13 2 A THR 8 2.26 -126.63 2 A SER 9 94.82 -0.52 2 A ILE 10 -90.65 -76.50 2 A SER 12 -160.59 -11.53 2 B VAL 2 65.71 -170.33 2 B ASN 3 -156.56 48.55 2 B GLN 4 154.16 141.03 2 B HIS 5 62.79 75.46 2 B LEU 6 -130.01 -72.81 2 B CYS 7 13.26 179.81 2 B VAL 12 -97.44 -68.86 2 B CYS 19 -93.01 -70.07 2 B PHE 25 -160.98 99.27 3 A ILE 2 56.03 146.07 3 A GLN 5 -128.98 -75.07 3 A THR 8 -74.93 -97.83 3 A SER 11 -32.21 -32.65 3 B VAL 2 -102.00 63.99 3 B ASN 3 -19.70 138.42 3 B GLN 4 80.58 113.87 3 B HIS 5 77.18 56.26 3 B LEU 6 -125.28 -74.93 3 B CYS 7 15.24 -157.29 3 B CYS 19 -104.55 -69.34 3 B GLU 21 -96.39 49.18 3 B PHE 24 -161.20 97.93 3 B PHE 25 -100.82 79.72 4 A ILE 2 -157.85 37.32 4 A VAL 3 -163.21 115.45 4 A GLU 4 -175.57 24.33 4 A GLN 5 -162.44 -90.63 4 A CYS 7 48.20 28.40 4 A THR 8 -18.63 -114.87 4 A SER 12 -160.72 92.80 4 B ASN 3 -177.04 142.67 4 B HIS 5 128.26 99.07 4 B LEU 6 -145.21 -61.72 4 B CYS 7 33.60 -159.46 4 B CYS 19 -82.85 -71.65 4 B GLU 21 -112.15 64.60 4 B TYR 26 42.39 -174.29 4 B LYS 28 -26.43 145.79 5 A ILE 2 -66.89 -173.84 5 A VAL 3 64.48 172.16 5 A GLU 4 86.28 -7.45 5 A GLN 5 -103.26 -95.53 5 A CYS 7 54.01 4.96 5 A THR 8 22.65 -150.99 5 A SER 9 108.06 7.40 5 A ILE 10 -129.81 -70.12 5 B ASN 3 67.70 146.24 5 B HIS 5 77.29 58.88 5 B CYS 7 -57.51 -162.31 5 B CYS 19 -66.40 -82.19 5 B ARG 22 159.89 30.84 5 B PHE 25 -143.52 51.59 5 B TYR 26 -38.74 148.96 5 B LYS 28 170.34 -53.55 6 A ILE 2 -123.89 -167.71 6 A VAL 3 -36.07 122.58 6 A GLN 5 -167.90 -96.35 6 A THR 8 23.91 75.31 6 A SER 11 34.08 34.48 6 A SER 12 -161.01 -31.18 6 B VAL 2 -178.47 63.74 6 B ASN 3 -164.63 70.44 6 B GLN 4 -50.93 175.30 6 B HIS 5 61.89 156.59 6 B LEU 6 138.70 -52.97 6 B CYS 7 22.99 -154.39 6 B CYS 19 -95.80 -65.68 6 B GLU 21 -114.33 68.39 6 B PHE 25 -153.73 60.10 7 A ILE 2 -61.95 94.03 7 A VAL 3 162.03 -19.47 7 A GLN 5 -77.08 -139.77 7 A THR 8 8.14 110.25 7 A SER 11 -103.26 45.84 7 A SER 12 -139.32 -43.00 7 A LEU 13 -34.48 -76.20 7 A LEU 16 -69.99 1.58 7 B ASN 3 48.98 124.18 7 B HIS 5 82.07 59.82 7 B CYS 7 11.16 -149.10 7 B SER 9 -52.77 -9.15 7 B GLU 21 -105.62 53.47 7 B PHE 25 -160.40 85.40 8 A VAL 3 83.64 -45.85 8 A GLN 5 -114.98 -140.92 8 A THR 8 -27.45 98.52 8 A ILE 10 -90.92 -79.76 8 A SER 11 -90.79 53.14 8 A SER 12 -160.45 -32.64 8 A GLU 17 -68.09 10.17 8 B HIS 5 67.25 93.62 8 B LEU 6 -144.52 -56.08 8 B CYS 7 25.18 -156.64 8 B CYS 19 -98.49 -71.74 8 B ARG 22 169.79 30.51 8 B PHE 25 -150.56 67.71 8 B LYS 28 169.01 -54.57 8 B PRO 29 -78.75 -168.45 9 A ILE 2 49.66 -176.37 9 A GLN 5 165.22 -90.81 9 A CYS 7 49.98 27.91 9 A THR 8 -25.32 89.03 9 A ILE 10 -82.39 -75.07 9 A SER 11 -88.56 46.90 9 A SER 12 -160.95 -29.74 9 B ASN 3 81.90 152.72 9 B HIS 5 74.37 100.00 9 B LEU 6 -145.95 -74.84 9 B CYS 7 33.57 177.39 9 B VAL 12 -94.59 -62.39 9 B CYS 19 -105.12 -64.64 9 B ARG 22 158.25 37.78 9 B PHE 25 -160.66 94.27 10 A VAL 3 51.56 -156.49 10 A GLN 5 -129.95 -137.13 10 A CYS 7 85.60 -31.07 10 A THR 8 34.29 32.28 10 A SER 11 53.51 19.54 10 A SER 12 -160.67 52.44 10 B ASN 3 78.25 145.90 10 B HIS 5 60.12 95.23 10 B LEU 6 -147.79 -58.74 10 B CYS 7 26.13 -158.17 10 B CYS 19 -110.69 -72.98 10 B PHE 25 -151.40 42.39 10 B LYS 28 33.32 71.22 model building X-PLOR refinement X-PLOR phasing X-PLOR HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES 1 N N 2 N N A LEU 13 A LEU 13 HELX_P A TYR 19 A TYR 19 1 1 7 B SER 9 B SER 9 HELX_P B CYS 19 B CYS 19 1 2 11 disulf 2.009 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.020 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 HORMONE HORMONE, HUMAN INSULIN, DISULFIDE MODEL INS_HUMAN UNP 1 90 P01308 INS_HUMAN UNP 2 25 P01308 90 110 1VKT 1 21 P01308 A 1 1 21 25 54 1VKT 1 30 P01308 B 2 1 30 1 CYS engineered mutation SER 6 1VKT A P01308 UNP 95 6 1 CYS engineered mutation SER 11 1VKT A P01308 UNP 100 11 2 HIS engineered mutation ASP 10 1VKT B P01308 UNP 34 10 2 PRO engineered mutation LYS 28 1VKT B P01308 UNP 52 28 2 LYS engineered mutation PRO 29 1VKT B P01308 UNP 53 29 1 P 1